Covalon Technologies Ltd
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more
Covalon Technologies Ltd (CVALF) - Total Assets
Latest total assets as of September 2025: $36.12 Million USD
Based on the latest financial reports, Covalon Technologies Ltd (CVALF) holds total assets worth $36.12 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Covalon Technologies Ltd - Total Assets Trend (2007–2025)
This chart illustrates how Covalon Technologies Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Covalon Technologies Ltd - Asset Composition Analysis
Current Asset Composition (September 2025)
Covalon Technologies Ltd's total assets of $36.12 Million consist of 87.3% current assets and 12.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 48.1% |
| Accounts Receivable | $5.84 Million | 16.2% |
| Inventory | $7.40 Million | 20.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.35 Million | 3.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2025)
This chart illustrates how Covalon Technologies Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Covalon Technologies Ltd's current assets represent 87.3% of total assets in 2025, an increase from 0.0% in 2007.
- Cash Position: Cash and equivalents constituted 48.1% of total assets in 2025, up from 34.2% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 2.0% in 2007.
- Asset Diversification: The largest asset category is inventory at 20.5% of total assets.
Covalon Technologies Ltd Competitors by Total Assets
Key competitors of Covalon Technologies Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Covalon Technologies Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Covalon Technologies Ltd generates 0.91x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Covalon Technologies Ltd generates $5.70 in net profit.
Covalon Technologies Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.36 | 7.27 | 0.63 |
| Quick Ratio | 6.40 | 5.34 | 0.30 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $27.76 Million | $ 25.04 Million | $ -8.00 Million |
Covalon Technologies Ltd - Advanced Valuation Insights
This section examines the relationship between Covalon Technologies Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.68 |
| Latest Market Cap to Assets Ratio | 0.73 |
| Asset Growth Rate (YoY) | 13.6% |
| Total Assets | $36.12 Million |
| Market Capitalization | $26.51 Million USD |
Valuation Analysis
Below Book Valuation: The market values Covalon Technologies Ltd's assets below their book value (0.73 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Covalon Technologies Ltd's assets grew by 13.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Covalon Technologies Ltd (2007–2025)
The table below shows the annual total assets of Covalon Technologies Ltd from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $36.12 Million | +13.57% |
| 2024-09-30 | $31.81 Million | +27.73% |
| 2023-09-30 | $24.90 Million | -18.03% |
| 2022-09-30 | $30.38 Million | -25.14% |
| 2021-09-30 | $40.58 Million | +16.96% |
| 2020-09-30 | $34.70 Million | -12.40% |
| 2019-09-30 | $39.61 Million | +100.97% |
| 2018-09-30 | $19.71 Million | +64.68% |
| 2017-09-30 | $11.97 Million | +84.43% |
| 2016-09-30 | $6.49 Million | -14.96% |
| 2015-09-30 | $7.63 Million | +7.34% |
| 2014-09-30 | $7.11 Million | +29.26% |
| 2013-09-30 | $5.50 Million | -9.42% |
| 2012-09-30 | $6.07 Million | -31.61% |
| 2011-09-30 | $8.88 Million | -11.48% |
| 2010-09-30 | $10.03 Million | -16.67% |
| 2009-09-30 | $12.03 Million | -25.92% |
| 2008-09-30 | $16.24 Million | -20.44% |
| 2007-09-30 | $20.42 Million | -- |